Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pacing Advancements With Cost and Experience VALuation for Unified Patient-Led Clinical Evidence - the PACEVALUE Study

NCT07276139 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.

NCT NCT07276139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07276139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pacing Advancements With Cost and Experience VALuation for Unified Patient-Led Clinical Evidence - the PACEVALUE Study
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2026
Completion date
January 1, 2031
Enrollment
4,500 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmias, cardiac, cardiomyopathy, secondary, conduction system pacing, heart failure, pacing induced cardiomyopathy